# CINC424A2X01B Rollover Protocol

> clinical trial · VERIFIED · 2026-06-22

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Primary Myelofibrosis

- Company: Novartis Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT02386800

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.